Navigation Links
Researcher studying biological factors of blood glucose variability wins 2013 IDF Europe Prize in Diabetes for Young Researcher
Date:11/13/2013

BRUSSELS, November 13, 2013 /PRNewswire/ --

Doctor Krisztina Lukacs of the Semmelweis University, Budapest (Hungary) was presented with the 2013 IDF Europe Prize in Diabetes for Young Researcher today at an award ceremony at the European Parliament in Brussels. The prize was awarded in recognition of her outstanding scientific work in the field of genetics and diabetes.

An internist and diabetologist, Krisztina Lukacs always had a strong interest in the role played by genetic factors in the development of diabetes. "While treating people with diabetes, I have witnessed a dramatic increase in both type 1 and type 2 diabetes in Hungary, as it is also the case in most European countries. One way to understand the mechanisms that cause diabetes is to study the genetic background of the disease. This is why I always saw a great opportunity in using the latest technologies in genetic testing to help understand what causes diabetes", she says. Since 2006, Doctor Lukacs has taken part in several patient-oriented clinical and basic research programmes focusing on the epidemiology, genetics and other mechanisms causing type 1 and type 2 diabetes.

Doctor Lukacs has currently embarked on a large population-based clinical study to determine the biological and environmental factors of severe hypoglycemia in people with type 1 diabetes. "The important variations in blood glucose levels that are partly caused by hypoglycemia can increase the risk of developing health complications, leading to a poor quality of life. These variations can also be considered the greatest barrier to achieve and maintain good metabolic control," she explains. "At the moment we have only limited knowledge about the possible role of genetic and environmental factors in glucose variability. In everyday clinical practice, we know that it is difficult for people with type 1 diabetes to control blood glucose levels under certain weather conditions, but the direct effects on glucose variability are not completely understood," she adds. The clinical study, led out of the Semmelweis University, will therefore try to identify new biomarkers and environmental factors that have an impact on glucose levels and the risk of hypoglycemia in type 1 diabetes.

As part of World Diabetes Day celebrations in the European Parliament in Brussels, Doctor Lukacs received today the IDF Europe Prize in Diabetes for Young Researcher. "We are pleased to hand over the prize to Doctor Krisztina Lukacs, said Professor Sehnaz Karadeniz, President Elect of IDF Europe and Chair of the prize's Nominating Committee. "Her scientific work aiming to better understand, predict and prevent hypoglycemia is undoubtedly a major contribution in improving the lives of people living with diabetes."

Doctor Lukacs was present in Brussels to receive the award personally. "It is an honour for me to receive this prize. Through our research, we strive to improve diabetes prediction, screening and treatment. Our ultimate goal is to improve the quality of life and the health outcomes for people living with diabetes," she said.

As the winner of the IDF Europe Prize in Diabetes for Young Research, Doctor Krisztina Lukacs will receive a cheque of 10,000 euros that she will donate to a charity of her choice.

An initiative led by the European Region of the International Diabetes Federation (IDF Europe), the Prize in Diabetes for Young Researcher is supported from Novartis Pharmaceuticals.

---------------------

About the IDF Europe Prize in Diabetes

Launched in 2012, the IDF Europe Prize in Diabetes rewards excellence, innovation and commitment in Diabetes.

This award also aims at increasing awareness of diabetes and recognizing outstanding individuals who have dedicated themselves to improving the lives of people with diabetes through their work and through research.

This year, IDF Europe is awarding two prizes: one in the category Long-Standing Achievement and one in the category Young Researcher.

AbouttheInternationalDiabetesFederationEuropeanRegion -IDFEurope

IDF Europe is the European Region of the International Diabetes Federation. We are an umbrella organisation uniting 66 diabetes associations in 47 countries. We represent people with diabetes and their families, as well as health professionals working in diabetes.

Through our work, we aim to influence policy, increase public awareness and encourage health improvement, promote the exchange of best practice and high-quality information about diabetes in all countries throughout the Region.

For more information, visit http://www.idf-europe.org.



'/>"/>
SOURCE International Diabetes Federation European Region (IDF Europe)
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
2. In new quantum-dot LED design, researchers turn troublesome molecules to their advantage
3. Multidisciplinary team of researchers develop world’s lightest material
4. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
5. Innovative MetaMorph® NX Software Shatters Barriers Between Researchers and Image Analysis Goals with Exclusive Visual Workflow
6. UCLA researchers demonstrate fully printed carbon nanotube transistor circuits for displays
7. Penn and Brown researchers demonstrate earthquake friction effect at the nanoscale
8. Two Top Biological Imaging Centers Offer Powerful Free Online Tool to Researchers, Educators, and Public
9. Researchers develop one of the worlds smallest electronic circuits
10. MU researchers identify key plant immune response in fight against bacteria
11. Researchers realize high-power, narrowband terahertz source at room temperature
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Feb. 12, 2016  PTC Therapeutics, Inc. ... annual STRIVE (Strategies to Realize Innovation, Vision and ... (DMD). STRIVE provides funds to patient advocacy organizations ... make meaningful contributions to the rare disease community ... of future patient advocates. Mary ...
(Date:2/11/2016)... NBIX ) today announced its financial results for the quarter ... --> For the fourth quarter of 2015, the ... per share, compared to a net loss of $19.4 million, or ... the year ended December 31, 2015, the Company reported a net ... to a net loss of $60.5 million, or $0.81 loss per ...
(Date:2/11/2016)... , Feb. 11, 2016  Bioethics International, a not-for-profit organization ... researched, developed, marketed and made accessible to patients around the ... had named the publication of the Good Pharma ... publication is also featured as one of BMJ Open ... last year that are most frequently read. Ed ...
(Date:2/11/2016)... (PRWEB) , ... February 11, ... ... business-to-business publication dedicated to delivering cutting-edge information focused on the development and ... Sciences to become a premier sponsor of the 2016 BioProcess International Awards ...
Breaking Biology Technology:
(Date:1/18/2016)... JOSE, Calif. , Jan. 18, 2016 /PRNewswire/ ... security software that simplifies the use and access ... technology and go-to-market partnership with American Cyber.  ... Cyber brings extensive experience leading transformational C4ISR and ... implementing and integrating the latest proven technology solutions," ...
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
(Date:1/11/2016)... , Jan. 11, 2016 Synaptics Incorporated ... interface solutions, today announced that its ClearPad ® ... (TDDI) products won two separate categories in the 8 ... Innovator and Best Technology Breakthrough. The Synaptics ® ... a simplified supply chain, thinner devices, brighter displays and ...
Breaking Biology News(10 mins):